Noninvasive Evaluation for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide and has the potential risk for progressing to nonalcoholic steatohepatitis (NASH), which is associated with a greater risk for complications of chronic liver disease. Noninvasive testing has been evaluated fo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical therapeutics 2021-03, Vol.43 (3), p.455-472
Hauptverfasser:	Kogachi, Shannon, Noureddin, Mazen
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Apolipoproteins Apoptosis Biomarkers Biopsy Body mass index Chemokines Clinical medicine Clinical trials Complications Diabetes Diagnosis Evaluation Fatty liver Health risks Inflammation Ligands Liver Liver diseases Medical imaging Monitoring MRI-PDFF NAFLD NASH noninvasive Noninvasive evaluation Proteins Risk Risk assessment serum biomarkers Spectrum analysis Telemedicine Tumor necrosis factor-TNF VCTE
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!